Xiaohui Luo - Publications

SMPD1 modulates malignant progress of osteosarcoma through ferroptosis pathway.

Journal: Tissue & cell

Published: October 11, 2025

DLST mediates the malignant progression of osteosarcoma cells by regulating the p38 MAPK signaling pathway.

Journal: Biochemical and biophysical research communications

Published: September 25, 2025

The Suitable Population for Opportunistic Low Bone Mineral Density Screening Using Computed Tomography.

Journal: Clinical interventions in aging

Published: January 24, 2024

Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells.

Journal: Gene

Published: October 22, 2023

LncRNA GClnc1 promotes osteosarcoma progression by stabilizing NONO and blocking FBXW7-mediated ubiquitination.

Journal: BMC cancer

Published: July 24, 2023

The synergistic anticancer effect of CBD and DOX in osteosarcoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 16, 2023

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4.

Journal: Frontiers in oncology

Published: January 07, 2023

Routine chest CT combined with the osteoporosis self-assessment tool for Asians (OSTA): a screening tool for patients with osteoporosis.

Journal: Skeletal radiology

Published: October 26, 2022